Gene · 6872
TAF1: TATA-box binding protein associated factor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TAF1: TATA-box binding protein associated factor 1. Genes, record 6872. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6872
On this page
Gene
- Aliases
- BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, MRXS33, N-TAF1, NSCL2, OF, P250, TAF(II)250, TAF2A, TAFII-250, TAFII250, XDP
- NCBI Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P21675 | Transcription initiation factor TFIID subunit 1 | 1,893 | 64 | Ensembl, GeneID, HGNC |
Source UniProt
Patents16
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 66346 | P21675 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2960 | P21675 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2526 | P21675 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2526 | P21675 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2960 | P21675 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 86513 | P21675 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 189484 | P21675 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 246781 | P21675 | Espacenet |
| JP 2017121241 A | 2017-07-13 | 246781 | P21675 | Espacenet |
| JP 2015516143 A | 2015-06-08 | 246781 | P21675 | Espacenet |
1 to 10 of 16
See all 16 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,544
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TAF1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 9 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| R01NS102423 | Assembling the Genetic Architecture of X-linked Dystonia Parkinsonism | 6 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| R01AI030612 | Virus-cell interactions affecting HSV gene expression | 5 | 2025 |
| ZIAHG200338 | Molecular Analyses of Endometrial Cancer | 5 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
1 to 10 of 1,544Source NIH's project files
See all 1,544 nih grantsPapers2,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unified long-read panel for Parkinson's and repeat expansion disorders. | NPJ Parkinsons Dis | 2026 | 42786195 | PubTator, text mining | PubMed |
| Pinoresinol as a Potential c-Myc Complex Modulator: An In Silico Study. | Curr Issues Mol Biol | 2026 | 42651832 | PubTator, text mining | PubMed |
| Tau isoform imbalance and aggregation are pathological hallmarks of X-linked dystonia-parkinsonism. | medRxiv | 2026 | 42619813 | PubTator, text mining | PubMed |
| Abidi Syndrome and Another Family With X-Linked Intellectual Disability Have TAF1 Variants and Reduced Phosphorylation of RNA Polymerase II Associated Protein 74. | Am J Med Genet A | 2026 | 42548218 | PubTator, text mining | PubMed |
| The Clinical, Genetic, Psychosocial, and Care Landscape of X-Linked Dystonia-Parkinsonism in Filipino Men: A Scoping Review. | Am J Mens Health | 2026 | 42531151 | PubTator, text mining | PubMed |
| Histone acetyltransferases as integrative epigenetic regulators of plant abiotic stress responses. | Plant Cell Rep | 2026 | 42463562 | PubTator, text mining | PubMed |
| Multi-omics analysis of arginine metabolism in ovarian cancer: A prognostic signature and GTF2F2-driven stromal remodeling. | Transl Oncol | 2026 | 42442222 | PubTator, text mining | PubMed |
| Single-molecule imaging reveals RNA polymerase II dynamics and TAF1-dependent promoter-proximal pause release. | Nat Commun | 2026 | 42323299 | PubTator, text mining | PubMed |
| A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latency. | mBio | 2026 | 42294674 | PubTator, text mining | PubMed |
| Synthesis and characterization of a novel phosphatidylinositol 5-phosphate (PI(5)P) photoaffinity probe. | RSC Chem Biol | 2026 | 42232647 | PubTator, text mining | PubMed |
1 to 10 of 2,090
See all 2,090 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6872
GET https://conductscience.org/api/genes/v1/6872/patents